Status:
COMPLETED
Consequences in ICU of Vaccination Status of Covid-19 Patients
Lead Sponsor:
Centre Hospitalier Régional Metz-Thionville
Conditions:
SARS CoV 2 Infection
Eligibility:
All Genders
18+ years
Brief Summary
It is a retrospective cohort study aiming to describe the characteristics, management and prognosis of vaccinated patients hospitalized in the intensive care unit (ICU), in comparison with non-vaccina...
Detailed Description
In December 2019 started the first wave of Sars-Cov-2 virus infections in Wuhan, China : the start of a major, deadly global pandemic, which has so far caused more than 6 million deaths worldwide. In ...
Eligibility Criteria
Inclusion
- Adult patient with Sars-Cov-2 pneumonia confirmed by positive reverse transcription polymerase chain reaction (RT-PCR) assay and hospitalized in the general intensive care unit of the CHR de Metz-Thionville, between 01/03/2020 and 01/06/2022.
Exclusion
- missing data for primary or secondary outcomes
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2023
Estimated Enrollment :
1058 Patients enrolled
Trial Details
Trial ID
NCT06191341
Start Date
January 1 2023
End Date
May 1 2023
Last Update
January 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHR Metz-Thionville/Hopital Mercy
Metz, France, 57085